Innoprot Innoprot is a dynamic and R&D intensive biotech focused on developing novel cell-based assays for High-Throughput Screening and High-Content analysis. Innoprot is owner of NOMAD technology for measuring second messengers concentration changes involved in GPCR activation and a wide range of assays mimmicking disease pathways. Innoprot also acts as a CRO providing drug screening services and on-demand assay development. Our goal is to accelerate and improve our customer’s drug discovery programs.